Neha Agrawal, M.D.
Assistant Professor
On This Page
About Neha Agrawal
Neha Agrawal, M.D., is a University of Florida assistant professor of medicine and a gastroenterologist at UF Health Jacksonville. She specializes in hepatology, caring for diseases and disorders of the liver, gallbladder and pancreas. Dr. Agrawal received her medical degree from Motilal Nehru Medical College – Allahabad University in Allahabad, India. She did her internal medicine residency at John H. Stroger Jr. Hospital of Cook County in Chicago, Illinois, and the University of Illinois College of Medicine at Urbana-Champaign in Urbana, Illinois. She completed fellowship training in hepatology at Temple University Hospital in Philadelphia, Pennsylvania.
Board Certifications
-
Internal MedicineAmerican Board of Internal Medicine
Clinical Profile
Specialties
- General Internal Medicine
Subspecialties
- Hepatology
Areas of Interest
- Alcoholic Liver Disease
- Ascites
- Autoimmune Hepatitis
- Cirrhosis
- Hepatitis
- Hepatitis B
- Hepatitis C
- Liver Cancer – Hepatocellular Carcinoma
- Nonalcoholic Fatty Liver Disease
- Portacaval Shunting
- Primary Biliary Cirrhosis
- Sclerosing Cholangitis
- Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Research Profile
Areas of Interest
- Hepatocellular carcinoma
- Liver Disease
- Non-alcoholic Fatty Liver Disease
Publications
Academic Articles
Grants
-
NN9500-7730: Effects of NNC0194-0499 alone and in combination with semaglutide, of semaglutide alone, and of cagrilintide alone and in combination with semaglutide on liver damage and alcohol use in people with alcohol-related liver disease
Active
- Role:
- Principal Investigator
- Funding:
- NOVO NORDISK A/S
-
A Randomized Double-blind Placebo-controlled Phase 3 Study to Evaluate the Effect of Resmetirom on Liver-related Outcomes in Patients with Well-compensated (Child-Pugh A) Non-alcoholic Steatohepatitis (NASH) Cirrhosis (MAESTRO-NASH OUTCOMES)
Active
- Role:
- Principal Investigator
- Funding:
- SYNEOS HEALTH via MADRIGAL PHARMACEUTICALS
-
Efficacy and safety investigation of NNC0194-0499 co-administered with semaglutide in subjects with non-alcoholic steatohepatitis: a dose-ranging, placebo controlled trial
Active
- Role:
- Principal Investigator
- Funding:
- NOVO NORDISK
-
A Phase 2, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Study Evaluating the Safety and Efficacy of Semaglutide, and the Fixed-Dose Combination of Cilofexor and Firsocostat, Alone and in Combination, in Subjects with Compensated Cirrhosis (F4) due to Nonalcoholic Steatohepatitis (NASH)
Active
- Role:
- Principal Investigator
- Funding:
- GILEAD SCIENCES
-
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients with Primary Biliary Cholangitis (VANTAGE)
Active
- Role:
- Principal Investigator
- Funding:
- SYNEOS HEALTH via MIRUM PHARMACEUTICALS
Education
-
Transplant Hepatology Fellowship
Temple University Hospital
-
Internal Medicine Residency
University of Illinois College of Medicine at Urbana-Champaign
-
Internal Medicine Residency
John H. Stroger, Jr. Hospital of Cook County
-
Bachelor of Medicine, Bachelor of Surgery
Motilal Nehru Medical College
Contact Details
- Business:
- (904) 244-8846
- Business:
- neha.agrawal@jax.ufl.edu
- Business Mailing:
-
653 W 8TH ST
JACKSONVILLE FL 32209 - Business Street:
-
653 W 8TH ST
JACKSONVILLE FL 32209